MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that a new study shows the unique combination of textures provided by the Company’s implant surface technology promotes superior production of angiogenic growth factors as compared with PEEK (poly-ether-ether-ketone) and smooth titanium alloy materials. The in-vitro research, currently available on The Spine Journal’s website and awaiting publication in an upcoming issue, demonstrated an approximate 100 percent increase in production of key angiogenic factors from osteoblast cells cultured on the Titan Spine surface versus PEEK.
Help employers find you! Check out all the jobs and post your resume.
